Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Qingdao NovelBeam Technology Co Days Payable?
Qingdao NovelBeam Technology CoSHSE:688677 -0.47%90 Days Payable is 109.32 as of Mar. 2026, which is 41% above its 10-year median of 77.74. GuruFocus rates SHSE:688677 with a GF Score™ of 90/100 and a GF Value™ of ¥63.03 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Qingdao NovelBeam Technology Co ranks better than 70.53% on this metric.
The historical rank and industry rank for Qingdao NovelBeam Technology Co's Days Payable or its related term are showing as below:
SHSE:688677'
s Days Payable Range Over the Past 10 Years
Min: 58.8 Med: 77.74 Max: 117.66
Current: 115.88
During the past 13 years, Qingdao NovelBeam Technology Co's highest Days Payable was 117.66. The lowest was 58.80. And the median was 77.74.
SHSE:688677's Days Payable is ranked better than 70.53% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs SHSE:688677: 115.88
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qingdao NovelBeam Technology Co Days Payable Chart
SHSE:688677 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Qingdao NovelBeam Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qingdao NovelBeam Technology Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qingdao NovelBeam Technology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Qingdao NovelBeam Technology Co's Days Payable falls into.
Qingdao NovelBeam Technology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qingdao NovelBeam Technology Co (SHSE:688677) has a Days Payable of 109.32 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Qingdao NovelBeam Technology Co and its competitors. This is 41% above median its historical median of 77.74. Over the past decade, Qingdao NovelBeam Technology Co's Days Payable has ranged from 58.80 to 117.66. According to the industry distribution chart, Qingdao NovelBeam Technology Co ranks #234 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 29.5%.
Is Qingdao NovelBeam Technology Co's Days Payable too high?
Qingdao NovelBeam Technology Co's current Days Payable of 109.32 is 41% above median its 10-year median of 77.74. Over the past 10 years, this metric has ranged from a low of 58.80 to a high of 117.66. The Medical Devices & Instruments industry median Days Payable is 67.85. Qingdao NovelBeam Technology Co's value of 109.32 is 61.1% above this industry median. Based on the distribution chart, Qingdao NovelBeam Technology Co ranks #234 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Qingdao NovelBeam Technology Co has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao NovelBeam Technology Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Qingdao NovelBeam Technology Co ranks #234 out of 794 companies for Days Payable. This puts Qingdao NovelBeam Technology Co in the upper half of its industry. The industry median Days Payable is 67.85. Qingdao NovelBeam Technology Co's value of 109.32 is 61.1% above this benchmark. Historically, Qingdao NovelBeam Technology Co's own Days Payable has ranged from 58.80 to 117.66 over the past decade. While the company's 10-year median is 77.74 vs. the industry median of 67.85, Qingdao NovelBeam Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qingdao NovelBeam Technology Co's current Days Payable of 109.32 is 61.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Qingdao NovelBeam Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qingdao NovelBeam Technology Co's current Days Payable is 109.32, which is 41% above median its own 10-year median of 77.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao NovelBeam Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao NovelBeam Technology Co (SHSE:688677) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥63.03, compared to a current price of ¥72.48 — trading 15% above its estimated fair value. The current Days Payable is 109.32, which is 41% above median its 10-year median of 77.74 and 61.1% above the Medical Devices & Instruments industry median of 67.85. Qingdao NovelBeam Technology Co's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Qingdao NovelBeam Technology Co (SHSE:688677), the current Days Payable is 109.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qingdao NovelBeam Technology Co (SHSE:688677) Overvalued in 2026?
Based on GuruFocus' analysis, Qingdao NovelBeam Technology Co stock appears to be overvalued.
The current stock price of ¥72.48 is trading 15% above its estimated GF Value™ of ¥63.03.
GuruFocus considers Qingdao NovelBeam Technology Co to be Modestly Overvalued.
Key valuation signals for SHSE:688677:
Days Payable: 109.32 (41% above median its 10-year median of 77.74)
GF Value™: ¥63.03 vs. price of ¥72.48 (15% above fair value)
Industry Position: 61.1% above the Medical Devices & Instruments median (#234 of 794)
No single metric tells the full story. See the SHSE:688677 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qingdao NovelBeam Technology Co Business Description
Qingdao NovelBeam Technology Co Ltd is engaged in the research and development, production and sales of medical endoscope equipment and optical products. The product portfolio of the group includes Endoscope, Camera coupler, Camera lens, Medical optics, Biometrics and others.
90GF Score
Get the complete analysis for SHSE:688677
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688677 has been successfully added to your 
